Track Every Form of Tirzepatide in One App
Tirzepatide is the same dual GIP/GLP-1 molecule whether you're on Mounjaro, Zepbound, or compounded tirzepatide from a pharmacy — and MeAgain tracks all three identically. Log your weekly injection, track side effects through the 6-step titration, monitor nutrition with the Capybara widget, and see your estimated tirzepatide levels between doses. MeAgain helps you feel like you again.
Last updated March 2026
What Features Does a Tirzepatide Tracking App Offer?
Injection Site Tracking Across 6 Dose Levels
Tirzepatide's 6-step titration runs from 2.5mg through 5mg, 7.5mg, 10mg, 12.5mg, and 15mg. MeAgain logs each injection by dose level and site — abdomen, thigh, or upper arm — with a rotation reminder so you're not reusing the same area. The same logging structure works for Mounjaro, Zepbound, and compounded tirzepatide.
Nutrition Tracking Tuned to Tirzepatide's Dual-Mechanism Appetite Suppression
Tirzepatide's simultaneous GLP-1 and GIP activation produces stronger appetite suppression than single-agonist GLP-1s. The Capybara home screen widget tracks protein, water, fiber, and steps in real time so you stay on nutrition targets even during the appetite suppression that makes eating feel unnecessary — especially important for preventing muscle loss.
Weight and Journey Tracking Across the Full Titration
Tirzepatide's dual-agonist mechanism often produces accelerating results as dose increases — and MeAgain's weight trend chart and Journey Cards make that visible. Log weight after every injection, see the trend across all 6 dose levels, and track dual-phone side-by-side comparisons of your weight and estimated levels charts.
Understanding Tirzepatide: One Molecule, Three Brand Forms
Tirzepatide is a dual GIP/GLP-1 receptor agonist — it simultaneously activates the GIP (glucose-dependent insulinotropic polypeptide) and GLP-1 (glucagon-like peptide-1) receptors. This dual-agonist mechanism is why tirzepatide is often called a "twincretin." The active molecule is identical across all three forms: Mounjaro (FDA-approved for type 2 diabetes), Zepbound (FDA-approved for weight loss), and compounded tirzepatide from licensed compounding pharmacies.
| Mounjaro | Zepbound | Compounded Tirzepatide | |
|---|---|---|---|
| Active molecule | Tirzepatide | Tirzepatide | Tirzepatide |
| FDA-approved use | Type 2 diabetes | Chronic weight management | Not FDA-approved (compounded) |
| Dose range | 2.5mg to 15mg | 2.5mg to 15mg | Varies by pharmacy |
| Pen format | KwikPen (pen colors) | Autoinjector | Vial or prefilled syringe |
| Insurance coverage | Often for diabetes | Often for obesity | Typically out-of-pocket |
| Tracking in MeAgain | Supported natively | Supported natively | Via custom medication |
Tirzepatide's 6-Step Titration Schedule
- 2.5mg — Weeks 1-4 (starting dose, tolerance building)
- 5mg — Weeks 5-8
- 7.5mg — Weeks 9-12
- 10mg — Weeks 13-16
- 12.5mg — Weeks 17-20
- 15mg — Week 21+ (maintenance dose for most subscribers)
MeAgain tracks Mounjaro, Zepbound, and compounded tirzepatide with the same injection log, estimated levels chart, and side effect timeline — because the molecule is identical regardless of which form you're taking. Your titration history is accurate and portable.
This content is for informational purposes only and does not constitute medical advice. Always consult your healthcare provider before starting or changing any medication. Compounded tirzepatide is not FDA-approved and is subject to availability from licensed compounding pharmacies.
How Can You Visualize Your Tirzepatide Progress?
See the Dual-Agonist Effect in Your Own Weight Data
Tirzepatide's GLP-1 + GIP dual mechanism often produces different weight loss rates at different dose levels — and some subscribers see accelerated results after reaching a therapeutic dose. MeAgain's weight trend chart and Journey Cards show that trajectory across all 6 levels so the dual-agonist payoff is visible in your data.
Side Effect Logging Across Six Adjustment Periods
Each of tirzepatide's 6 dose steps is a distinct adjustment period. Log nausea, fatigue, constipation, and custom symptoms with a severity slider at every level so you can see exactly when tirzepatide side effects peak and when they ease. The same log applies whether you're on Mounjaro, Zepbound, or compounded.
A Complete Tirzepatide Record for Your Health Partner
Tirzepatide's 6-step titration spans 5+ months. Your MeAgain log captures every dose level, injection site, side effect pattern, and weight milestone — so your health partner has a full tirzepatide history at every visit regardless of which brand you're taking.
What Are Tirzepatide Users Tracking?
Join the Community
Subscribers on Mounjaro, Zepbound, and compounded tirzepatide all use MeAgain's same core tracking features — because the molecule and the experience are the same. The most common use: comparing side effect severity and weight trends across dose levels to understand which step of the titration is their personal turning point.
Over 286,000 people are on their GLP-1 journey with MeAgain — including thousands of subscribers across all three tirzepatide forms. For eligible subscribers, zero markup compounded tirzepatide is available in-app at $199/mo with no commitments.
What Our Users Say
Tirzepatide Tracker - Your Questions Answered
Mounjaro, Zepbound, and compounded tirzepatide all contain the same active molecule — tirzepatide — but differ by FDA indication and source: Mounjaro is approved for type 2 diabetes, Zepbound for chronic weight management, and compounded tirzepatide is produced by licensed pharmacies as an alternative when brand versions aren't accessible. MeAgain tracks all three with the same logging features.
Your Journey Back to You,
One Day at a Time
Track the plan, dose, meals, and milestones in one place that actually keeps up with your day.